Optimal Cut-Offs of Body Mass Index and Waist Circumference to Identify Obesity in Chinese Type 2 Diabetic Patients.
body mass index
diagnostic test
dual-energy X-ray absorptiometry
type 2 diabetes
waist circumference
Journal
Diabetes, metabolic syndrome and obesity : targets and therapy
ISSN: 1178-7007
Titre abrégé: Diabetes Metab Syndr Obes
Pays: New Zealand
ID NLM: 101515585
Informations de publication
Date de publication:
2020
2020
Historique:
received:
27
02
2020
accepted:
13
05
2020
entrez:
26
6
2020
pubmed:
26
6
2020
medline:
26
6
2020
Statut:
epublish
Résumé
The prevalence of general obesity (commonly defined by body mass index (BMI) in kg/m BMI and WC were obtained from 1539 type 2 diabetic patients. Body fat percentage and visceral fat area measured by dual-energy x-ray absorptiometry were set as the gold standard to identify general and abdominal obesity. We assessed the diagnostic power of traditional cut-offs for BMI and WC to define obesity, and analyzed receive operating characteristic (ROC) curves to obtain the optimal cut-offs to identify obesity in Chinese type 2 diabetic patients. In Chinese type 2 diabetic patients, the optimal BMI was 25 kg/m For the Chinese patients with type 2 diabetes, the optimal cut-offs for BMI or WC to identify general or abdominal obesity need to be reconsidered.
Identifiants
pubmed: 32581564
doi: 10.2147/DMSO.S251574
pii: 251574
pmc: PMC7278219
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1899-1909Informations de copyright
© 2020 Zhao et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Diabetes Care. 2009 Nov;32(11):1993-7
pubmed: 19549734
JAMA. 2005 Apr 20;293(15):1861-7
pubmed: 15840860
JAMA. 2002 Oct 9;288(14):1723-7
pubmed: 12365955
JAMA. 2006 Jan 11;295(2):190-8
pubmed: 16403931
World Health Organ Tech Rep Ser. 1995;854:1-452
pubmed: 8594834
Am J Hum Biol. 2017 Jan;29(1):
pubmed: 27427402
MMWR Morb Mortal Wkly Rep. 2003 Sep 5;52(35):833-7
pubmed: 12966357
JAMA. 2005 Apr 20;293(15):1868-74
pubmed: 15840861
Am J Clin Nutr. 2004 Mar;79(3):379-84
pubmed: 14985210
Clin Exp Pharmacol Physiol. 2012 Apr;39(4):393-8
pubmed: 22320261
Diabetes Metab J. 2017 Feb;41(1):51-59
pubmed: 28029016
N Engl J Med. 2010 Mar 25;362(12):1090-101
pubmed: 20335585
Int J Obes (Lond). 2016 May;40(5):761-7
pubmed: 26620887
JAMA. 2001 May 16;285(19):2486-97
pubmed: 11368702
Diabetes Res Clin Pract. 2010 Jan;87(1):4-14
pubmed: 19896746
J Am Soc Nephrol. 2006 Oct;17(10):2937-44
pubmed: 16988059
J Clin Endocrinol Metab. 1991 Oct;73(4):691-5
pubmed: 1890146
Eur J Clin Invest. 2002 Jun;32 Suppl 3:24-34
pubmed: 12028372
Nutr Diabetes. 2016 Jul 18;6(7):e221
pubmed: 27428873
Am J Clin Nutr. 2001 Jan;73(1):123-6
pubmed: 11124761
Obesity (Silver Spring). 2012 May;20(5):1109-14
pubmed: 22240726
Arch Intern Med. 2002 Sep 9;162(16):1867-72
pubmed: 12196085
Metabolism. 1987 Jan;36(1):54-9
pubmed: 3796297
J Clin Densitom. 2019 Mar 20;:
pubmed: 30992223
J Clin Endocrinol Metab. 2016 Oct;101(10):3740-3746
pubmed: 27490920
J Endocrinol Invest. 1999;22(5 Suppl):110-6
pubmed: 10442580
JAMA. 2013 Sep 4;310(9):948-59
pubmed: 24002281
Circ J. 2002 Nov;66(11):987-92
pubmed: 12419927
Eur J Clin Nutr. 2008 Nov;62(11):1302-7
pubmed: 17637598
Obesity (Silver Spring). 2012 Jun;20(6):1313-8
pubmed: 22282048
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
Int J Obes (Lond). 2008 Jun;32(6):959-66
pubmed: 18283284
Int J Obes (Lond). 2008 May;32(5):780-7
pubmed: 18227843
Am J Cardiol. 2013 Nov 15;112(10):1592-8
pubmed: 23993123
Obesity (Silver Spring). 2013 Jan;21(1):E154-61
pubmed: 23505198
Eur Heart J. 2007 Sep;28(17):2087-93
pubmed: 17626030
J Diabetes Complications. 2014 Sep-Oct;28(5):679-83
pubmed: 24973938